Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.

MLA

Chen, Xinping, et al. “Oestrogen Inhibition Reverses Pulmonary Arterial Hypertension and Associated Metabolic Defects.” The European Respiratory Journal, vol. 50, no. 2, Aug. 2017. EBSCOhost, https://doi.org/10.1183/13993003.02337-2016.

APA

Chen, X., Austin, E. D., Talati, M., Fessel, J. P., Farber-Eger, E. H., Brittain, E. L., Hemnes, A. R., Loyd, J. E., & West, J. (2017). Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. The European Respiratory Journal, 50(2). https://doi.org/10.1183/13993003.02337-2016

Chicago

Chen, Xinping, Eric D Austin, Megha Talati, Joshua P Fessel, Eric H Farber-Eger, Evan L Brittain, Anna R Hemnes, James E Loyd, and James West. 2017. “Oestrogen Inhibition Reverses Pulmonary Arterial Hypertension and Associated Metabolic Defects.” The European Respiratory Journal 50 (2). doi:10.1183/13993003.02337-2016.